167 related articles for article (PubMed ID: 28277316)
41. Clinical and Ultrasound Characteristics of the Microcystic Elongated and Fragmented (MELF) Pattern in Endometrial Cancer According to the International Endometrial Tumor Analysis (IETA) criteria.
Eriksson LSE; Nastic D; Frühauf F; Fischerova D; Nemejcova K; Bono F; Franchi D; Fruscio R; Ghioni M; Haak LA; Hejda V; Meskauskas R; Opolskiene G; Pascual MA; Testa A; Tresserra F; Zannoni GF; Carlson JW; Epstein E
Int J Gynecol Cancer; 2019 Jan; 29(1):119-125. PubMed ID: 30640693
[TBL] [Abstract][Full Text] [Related]
42. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
[TBL] [Abstract][Full Text] [Related]
43. CXCL14 is no direct modulator of CXCR4.
Otte M; Kliewer A; Schütz D; Reimann C; Schulz S; Stumm R
FEBS Lett; 2014 Dec; 588(24):4769-75. PubMed ID: 25451233
[TBL] [Abstract][Full Text] [Related]
44. Clinicopathologic association and prognostic impact of microcystic, elongated and fragmented pattern invasion, combined with tumor budding in endometrioid endometrial cancer.
Qi X; Zhu L; Zhang B
J Obstet Gynaecol Res; 2022 Sep; 48(9):2431-2441. PubMed ID: 35769021
[TBL] [Abstract][Full Text] [Related]
45. [Significance of expression of stromal cell derived factor 1 and CXCR4 in invasive breast cancer].
Liu FF; Wei J; Lang RG; Fan Y; Cui LF; Gu F; Fu L
Zhonghua Bing Li Xue Za Zhi; 2008 Aug; 37(8):529-35. PubMed ID: 19094464
[TBL] [Abstract][Full Text] [Related]
46. Nicotinamide N-methyltransferase is related to MELF pattern invasion in endometrioid carcinoma.
Tahara S; Nojima S; Ohshima K; Hori Y; Sato K; Kurashige M; Matsui T; Okuzaki D; Morii E
Cancer Med; 2021 Dec; 10(23):8630-8640. PubMed ID: 34655178
[TBL] [Abstract][Full Text] [Related]
47. Microcystic elongated and fragmented (MELF) pattern of invasion: Molecular features and prognostic significance in the PORTEC-1 and -2 trials.
van den Heerik ASVM; Aiyer KTS; Stelloo E; Jürgenliemk-Schulz IM; Lutgens LCHW; Jobsen JJ; Mens JWM; van der Steen-Banasik EM; Creutzberg CL; Smit VTHBM; Horeweg N; Bosse T
Gynecol Oncol; 2022 Sep; 166(3):530-537. PubMed ID: 35840357
[TBL] [Abstract][Full Text] [Related]
48. Upregulation of CXC chemokine receptor 4-CXC chemokine ligand 12 axis ininvasive breast carcinoma: A potent biomarker predicting lymph node metastasis.
Dayer R; Babashah S; Jamshidi S; Sadeghizadeh M
J Cancer Res Ther; 2018; 14(2):345-350. PubMed ID: 29516917
[TBL] [Abstract][Full Text] [Related]
49. MELF pattern invasion in endometrial carcinoma: association with low grade, myoinvasive endometrioid tumours, focal mucinous differentiation and vascular invasion.
Stewart CJ; Brennan BA; Leung YC; Little L
Pathology; 2009; 41(5):454-9. PubMed ID: 19900084
[TBL] [Abstract][Full Text] [Related]
50. CXCL14, CXCR7 expression and CXCR4 splice variant ratio associate with survival and metastases in Ewing sarcoma patients.
Sand LG; Scotlandi K; Berghuis D; Snaar-Jagalska BE; Picci P; Schmidt T; Szuhai K; Hogendoorn PC
Eur J Cancer; 2015 Nov; 51(17):2624-33. PubMed ID: 26428435
[TBL] [Abstract][Full Text] [Related]
51. Expression of CXCL12 and its receptor CXCR4 correlates with lymph node metastasis in submucosal esophageal cancer.
Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Sakurai T; Owaki T; Aikou T
J Surg Oncol; 2008 Apr; 97(5):433-8. PubMed ID: 18176915
[TBL] [Abstract][Full Text] [Related]
52. Dimeric peptides of the C-terminal region of CXCL14 function as CXCL12 inhibitors.
Tanegashima K; Tsuji K; Suzuki K; Shigenaga A; Otaka A; Hara T
FEBS Lett; 2013 Nov; 587(23):3770-5. PubMed ID: 24161674
[TBL] [Abstract][Full Text] [Related]
53. Comparative expression pattern analysis of the highly conserved chemokines SDF1 and CXCL14 during amniote embryonic development.
García-Andrés C; Torres M
Dev Dyn; 2010 Oct; 239(10):2769-77. PubMed ID: 21038449
[TBL] [Abstract][Full Text] [Related]
54. Dual expression of immunoreactive estrogen receptor β and p53 is a potential predictor of regional lymph node metastasis and postoperative recurrence in endometrial endometrioid carcinoma.
Obata T; Nakamura M; Mizumoto Y; Iizuka T; Ono M; Terakawa J; Daikoku T; Fujiwara H
PLoS One; 2017; 12(11):e0188641. PubMed ID: 29190668
[TBL] [Abstract][Full Text] [Related]
55. The CXCR4/CXCL12 axis in endometrial cancer.
Gelmini S; Mangoni M; Castiglione F; Beltrami C; Pieralli A; Andersson KL; Fambrini M; Taddei GL; Serio M; Orlando C
Clin Exp Metastasis; 2009; 26(3):261-8. PubMed ID: 19199057
[TBL] [Abstract][Full Text] [Related]
56. CD147 (EMMPRIN) and matrix metalloproteinase-2 expression in uterine endometrioid adenocarcinoma.
Stewart CJ; Crook ML
Pathol Res Pract; 2011 Jan; 207(1):30-6. PubMed ID: 21144675
[TBL] [Abstract][Full Text] [Related]
57. [Correlation of CXCR4/CXCL12 overexpression to lymph node metastasis and chronic inflammation in cervical adenocarcinoma].
Wei M; Liang LZ; Zhang CQ; Xiong Y; Zhang Y; Shen Y; Li JQ
Ai Zheng; 2007 Mar; 26(3):298-302. PubMed ID: 17355795
[TBL] [Abstract][Full Text] [Related]
58. L1CAM Expression is Related to Non-Endometrioid Histology, and Prognostic for Poor Outcome in Endometrioid Endometrial Carcinoma.
Geels YP; Pijnenborg JM; Gordon BB; Fogel M; Altevogt P; Masadah R; Bulten J; van Kempen LC; Massuger LF
Pathol Oncol Res; 2016 Oct; 22(4):863-8. PubMed ID: 26891628
[TBL] [Abstract][Full Text] [Related]
59. Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis.
Pan J; Mestas J; Burdick MD; Phillips RJ; Thomas GV; Reckamp K; Belperio JA; Strieter RM
Mol Cancer; 2006 Nov; 5():56. PubMed ID: 17083723
[TBL] [Abstract][Full Text] [Related]
60. Tumor-associated macrophages correlate with vascular space invasion and myometrial invasion in endometrial carcinoma.
Soeda S; Nakamura N; Ozeki T; Nishiyama H; Hojo H; Yamada H; Abe M; Sato A
Gynecol Oncol; 2008 Apr; 109(1):122-8. PubMed ID: 18289648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
